Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ZOGENIX, INC. | 9,923,335 | reported | 16 Sept 2011 | tx 20+10,102,586−4,252,587 |
| ACHILLION PHARMACEUTICALS INC | 5,772,968 | reported | 18 Jan 2013 | tx 5+184,896−2,200,000 |
| ALIMERA SCIENCES INC | 3,898,207 | reported | 19 Jun 2013 | tx 17+4,896,341−5,266,978 |
| NOVACEA INC | 2,907,523 | reported | 30 Jan 2009 | tx 21+8,089,674−1,274,500 |
| SANTARUS INC | 2,729,197 | reported | 06 Apr 2004 | tx 6+2,793,668−2,793,668 |
| Northstar Neuroscience, Inc. | 2,068,500 | reported | 10 May 2006 | tx 7+2,106,086−3,159,129 |
| Volcano CORP | 1,868,540 | reported | 16 Jul 2008 | tx 71+10,183,585−19,952,097 |
| Syndax Pharmaceuticals Inc | 1,743,854 | reported | 08 Mar 2016 | tx 6+1,749,495−1,749,495 |
| Otonomy, Inc. | 1,329,323 | reported | 28 May 2015 | tx 2+32,745−250,000 |
| Esperion Therapeutics, Inc. | 70,042 | reported | 01 Jul 2013 | tx 10+2,173,423−2,314,140 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Nov 2019 | SALE | REVA Medical, Inc. | 15,500 | 0.00 USD | |
| 11 Nov 2019 | SALE | REVA Medical, Inc. | 15,500 | 0.00 USD | |
| 11 Nov 2019 | SALE | REVA Medical, Inc. | 3,606,002 | — | |
| 11 Nov 2019 | SALE | REVA Medical, Inc. | 85,186 | — | |
| 29 Jun 2018 | OTHER | REVA Medical, Inc. | 3,000 | 0.00 USD | |
| 29 Jun 2018 | OTHER | REVA Medical, Inc. | 3,000 | 0.00 USD | |
| 16 May 2018 | GRANT_AWARD | REVA Medical, Inc. | 25,000 | 0.00 USD | deriv |
| 11 Dec 2017 | OTHER | TRANZYME INC | 1,857,036 | — | |
| 11 Dec 2017 | OTHER | TRANZYME INC | 20,150 | 0.00 USD | deriv |
| 11 Dec 2017 | OTHER | TRANZYME INC | 20,150 | 0.00 USD | deriv |
| 25 Jul 2017 | OTHER | REVA Medical, Inc. | 5,000 | 0.00 USD | |
| 25 Jul 2017 | OTHER | REVA Medical, Inc. | 5,000 | 0.00 USD | |
| 14 Jul 2017 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 09 Jul 2017 | GRANT_AWARD | REVA Medical, Inc. | 6,000 | 0.00 USD | |
| 09 Jul 2017 | GRANT_AWARD | REVA Medical, Inc. | 10,500 | 0.00 USD | deriv |
| 01 Nov 2016 | TENDER | Regado Biosciences Inc | 3,553,322 | 28.35 USD | |
| 12 Oct 2016 | CONVERSION | OBALON THERAPEUTICS INC | 3,985,970 | — | |
| 12 Oct 2016 | CONVERSION | OBALON THERAPEUTICS INC | 836,722 | 0.00 USD | deriv |
| 12 Oct 2016 | CONVERSION | OBALON THERAPEUTICS INC | 649,835 | 0.00 USD | deriv |
| 12 Oct 2016 | CONVERSION | OBALON THERAPEUTICS INC | 482,326 | 0.00 USD | deriv |
| 12 Oct 2016 | CONVERSION | OBALON THERAPEUTICS INC | 1,206,836 | 0.00 USD | deriv |
| 12 Oct 2016 | CONVERSION | OBALON THERAPEUTICS INC | 597,207 | 0.00 USD | deriv |
| 01 Aug 2016 | SALE | CoLucid Pharmaceuticals, Inc. | 52,216 | 8.82 USD | |
| 03 Aug 2016 | SALE | CoLucid Pharmaceuticals, Inc. | 81,094 | 8.15 USD | |
| 02 Aug 2016 | SALE | CoLucid Pharmaceuticals, Inc. | 19,718 | 8.71 USD |
1 purchase reported after at least 12 months of silence — most recent on 08 Dec 2008.